Sugammadex 200mg/2ml solution for injection vials
NHS hospitals in England used £33,569,246 of indicative cost of Sugammadex 200mg/2ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 17.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Sugammadex 200mg/2ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Sugammadex 200mg/2ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £1,207,351 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,154,140 |
| Southend Univ Hosp Nhs Foundation Trust | £927,584 |
| Barts Health Nhs Trust | £868,186 |
| Norfolk & Norwich University Hpl Nhs Trt | £725,648 |
| Manchester University Nhs Ft | £713,150 |
| Nottingham University Hospitals Trust | £696,848 |
| Royal Free London Nhs Foundation Trust | £679,668 |
| Western Sussex Hospitals Nhs Found Trust | £674,861 |
| Portsmouth Hospitals Nhs Trust | £622,402 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.